Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.160
-0.030 (-1.37%)
At close: Apr 3, 2025
17.07%
Market Cap 1.45B
Revenue (ttm) 686.57M
Net Income (ttm) 99.42M
Shares Out 671.34M
EPS (ttm) 0.15
PE Ratio 14.59
Forward PE n/a
Dividend 0.08 (3.79%)
Ex-Dividend Date Sep 25, 2025
Volume 229,677
Average Volume 226,448
Open 2.190
Previous Close 2.190
Day's Range 2.150 - 2.200
52-Week Range 1.815 - 3.440
Beta 0.09
RSI 26.83
Earnings Date Apr 10, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company produces medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, ... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,350
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2024, Antibiotice's revenue was 686.57 million, an increase of 11.58% compared to the previous year's 615.29 million. Earnings were 99.42 million, an increase of 22.60%.

Financial Statements

News

There is no news available yet.